Immune checkpoint inhibitors (ICIs) are a mainstay of immunotherapy for many cancer types — including breast, colon, liver, lung, skin, stomach, and rectal — but cancer care often brings challenging skin side effects that patients (and even physicians) may not expect.
High rate of subsequent cancers in MCC
Our study does confirm that patients with MCC are at higher risk for developing other cancers,” study author Lisa C. Zaba, MD, PhD, associate professor of dermatology and director of the Merkel cell carcinoma multidisciplinary clinic, Stanford (Calif.) Cancer Center, said in an interview. “MCC is a highly malignant cancer with a 40% recurrence risk.
What to Know About Merkel Cell Carcinoma, the Cause of Jimmy Buffett's Death
Merkel cell carcinoma isn’t as common as other types of skin cancers, like basal cell carcinoma or melanoma, and tends to be more aggressive."
Nghiem Lab & Research Partners Awarded $400K Grant for MCC Research
UW Dermatology’s Nghiem Lab Research Team, and collaborators from the Fred Hutchinson Cancer Center and Stanford Medicine, whose recent proposal was selected to receive a two-year $391,280 grant by the Kuni Foundation
Tips for Diagnosing and Managing MCC
The Science Behind Using Circulating Tumor DNA for MCC
Women’s immune system genes operate differently from men’s
Immunotherapy for Kaposi Sarcoma
Hair Loss
COVID-19 Boosters and Psoriasis
“You should talk to the physician you see for psoriasis treatment to [get their input] and determine if you are on an immunosuppressive medication prior to getting the booster shot,”
COVID Vaccine and Psoriasis
Single-stranded mRNA molecules, like those contained in the Pfizer and Moderna COVID-19 vaccines, are activators of innate immune cells. Binding of mRNA to innate immune cells produces a potent type I interferon (IFN) response that is thought to play a central role in inflammation in some patients with autoimmune disorders. [Specifically,] type I IFN is thought to play a role in the initiation phase of psoriasis when people first develop the disease, although chronic psoriasis is perpetuated by overactivation of a different pathway, the Th17 adaptive immune response.